Free Trial
→ Iran's New Leader Just Said Something That Should Terrify Every American (From American Alternative) (Ad)tc pixel Free OPRX Stock Alerts

OptimizeRx (OPRX) Institutional Ownership

OptimizeRx logo
$5.26 +0.36 (+7.23%)
As of 02:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for OptimizeRx (NASDAQ:OPRX)

Current
Institutional Ownership
Percentage
76.47%
Number of
Institutional Buyers
(last 12 months)
72
Total
Institutional Inflows
(last 12 months)
$67.36M
Number of
Institutional Sellers
(last 12 months)
30
Total
Institutional Outflows
(last 12 months)
$20.52M
Get OPRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling OptimizeRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OPRX Institutional Buying and Selling by Quarter

OptimizeRx Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Sei Investments Co.98,633$619K0.0%+83.4%0.526%
5/14/2026State of Wyoming35,251$221K0.0%+234.6%0.188%
5/13/2026Cetera Investment Advisers27,544$173K0.0%N/A0.147%
5/7/2026 Dimensional Fund Advisors LP563,570$3.54M0.0%+22.3%3.004%
5/5/2026 Bank of New York Mellon Corp102,374$643K0.0%-10.4%0.546%
5/4/2026 Principal Financial Group Inc.63,790$401K0.0%+131.7%0.340%
4/30/2026 Hsbc Holdings PLC13,286$85K0.0%N/A0.071%
4/21/2026 Aaron Wealth Advisors LLC10,588$66K0.0%N/A0.056%
2/18/2026Millennium Management LLC43,669$535K0.0%N/A0.234%
2/18/2026Manatuck Hill Partners LLC422,107$5.18M1.8%-10.6%2.264%
2/18/2026 Inspire Investing LLC95,880$1.18M0.1%N/A0.514%
2/18/2026Engineers Gate Manager LP18,634$228K0.0%N/A0.100%
2/18/2026Boothbay Fund Management LLC73,488$901K0.0%+53.1%0.394%
2/18/2026Bridgeway Capital Management LLC69,029$846K0.0%+16.9%0.370%
2/17/2026Schonfeld Strategic Advisors LLC98,170$1.20M0.0%+59.2%0.527%
2/17/2026AQR Capital Management LLC14,514$178K0.0%+18.4%0.078%
2/17/2026 Russell Investments Group Ltd.289,060$3.54M0.0%+35.5%1.551%
2/17/2026Granahan Investment Management LLC117,122$1.44M0.1%+64.9%0.628%
2/17/2026State of Wisconsin Investment Board53,094$651K0.0%+92.6%0.285%
2/17/2026ExodusPoint Capital Management LP12,252$150K0.0%N/A0.066%
2/17/2026 Blair William & Co. IL582,585$7.14M0.0%-1.4%3.125%
2/17/2026Rice Hall James & Associates LLC590,674$7.24M0.4%+8.2%3.169%
2/16/2026Squarepoint Ops LLC206,961$2.54M0.0%+48.8%1.110%
2/16/2026Next Century Growth Investors LLC505,407$6.20M0.4%+139.8%2.711%
2/16/2026Barclays PLC27,441$336K0.0%+18.7%0.147%
2/13/2026Marshall Wace LLP19,825$243K0.0%-44.0%0.106%
2/13/2026Virtus Advisers LLC9,687$119K0.1%-61.5%0.052%
2/13/2026Charles Schwab Investment Management Inc.81,318$997K0.0%+8.2%0.436%
2/13/2026State Street Corp477,531$5.86M0.0%+21.6%2.562%
2/13/2026 Wells Fargo & Company MN28,903$354K0.0%+35.5%0.155%
2/12/2026HRT Financial LP17,295$212K0.0%N/A0.093%
2/12/2026MetLife Investment Management LLC9,844$121K0.0%-13.5%0.053%
2/12/2026Renaissance Technologies LLC29,578$363K0.0%-72.6%0.159%
2/12/2026 Dimensional Fund Advisors LP460,909$5.65M0.0%+16.0%2.473%
2/12/2026Campbell & CO Investment Adviser LLC12,908$158K0.0%N/A0.069%
2/12/2026 Nuveen LLC38,786$476K0.0%-12.1%0.208%
2/11/2026GWN Securities Inc.22,358$274K0.1%N/A0.120%
2/11/2026 LPL Financial LLC26,698$327K0.0%-5.9%0.143%
2/11/2026Franklin Resources Inc.16,284$200K0.0%-43.1%0.087%
2/11/2026 CenterBook Partners LP25,224$309K0.0%-91.8%0.135%
NNVC FDA = New Momentum Wave! (Ad)

NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance.tc pixel

See why this FDA milestone could be a catalyst for NNVC
2/11/2026 Los Angeles Capital Management LLC44,577$547K0.0%-8.1%0.239%
2/11/2026State of Wyoming10,535$129K0.0%-51.7%0.057%
2/10/2026Goldman Sachs Group Inc.127,014$1.56M0.0%-6.9%0.681%
2/10/2026 P.A.W. Capital Corp55,000$674K1.5%+10.0%0.295%
2/10/2026 Hillsdale Investment Management Inc.20,300$249K0.0%+10.9%0.109%
2/9/2026Geode Capital Management LLC396,468$4.86M0.0%+3.5%2.127%
2/9/2026 Royce & Associates LP682,030$8.36M0.1%+0.7%3.659%
2/4/2026 Perkins Capital Management Inc.17,408$213K0.2%-53.7%0.093%
1/29/2026 Calamos Advisors LLC97,118$1.19M0.0%+26.1%0.521%
1/23/2026 State of Alaska Department of Revenue5,067$62K0.0%N/A0.027%
1/20/2026 Harbor Capital Advisors Inc.24,876$305K0.0%+12.2%0.133%
1/1/2026JPMorgan Chase & Co.6,564$135K0.0%-20.3%0.035%
11/25/2025Connors Investor Services Inc.9,819$201K0.0%-55.5%0.053%
11/17/2025Harvest Investment Services LLC167,837$3.44M0.7%N/A0.900%
11/17/2025Worth Venture Partners LLC10,750$220K0.6%N/A0.058%
11/17/2025Virtus Advisers LLC25,187$516K0.3%N/A0.135%
11/17/2025Qube Research & Technologies Ltd18,583$381K0.0%N/A0.100%
11/17/2025Parkman Healthcare Partners LLC509,611$10.45M1.1%+0.4%2.734%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,230$148K0.0%-24.4%0.039%
11/17/2025Granahan Investment Management LLC71,046$1.46M0.1%N/A0.381%
11/17/2025Bank of America Corp DE84,760$1.74M0.0%+147.5%0.455%
11/17/2025Boothbay Fund Management LLC47,986$984K0.0%N/A0.257%
11/14/2025Schonfeld Strategic Advisors LLC61,648$1.26M0.0%-74.7%0.331%
11/14/2025 Creative Planning16,159$331K0.0%N/A0.087%
11/14/2025Manatuck Hill Partners LLC472,307$9.68M3.2%+3.8%2.534%
11/14/2025Two Sigma Investments LP63,704$1.31M0.0%-38.0%0.342%
11/14/2025Bridgeway Capital Management LLC59,029$1.21M0.0%-40.4%0.317%
11/14/2025Squarepoint Ops LLC139,077$2.85M0.0%N/A0.746%
11/13/2025Kennedy Capital Management LLC674,918$13.84M0.3%+42.8%3.621%
11/13/2025 Invesco Ltd.199,091$4.08M0.0%N/A1.068%
11/13/2025 UBS Group AG34,086$699K0.0%-66.8%0.183%
11/13/2025Franklin Resources Inc.28,630$587K0.0%N/A0.154%
11/13/2025 Russell Investments Group Ltd.213,298$4.37M0.0%+92.8%1.144%
11/13/2025 Blair William & Co. IL591,139$12.12M0.0%-6.0%3.171%
11/12/2025Integrated Quantitative Investments LLC18,483$379K0.1%N/A0.099%
11/12/2025 Dimensional Fund Advisors LP397,302$8.15M0.0%+3.3%2.131%
11/12/2025 Royce & Associates LP677,330$13.89M0.1%-14.3%3.634%
11/10/2025 Hillsdale Investment Management Inc.18,300$375K0.0%N/A0.099%
11/7/2025 CenterBook Partners LP308,809$6.33M0.3%N/A1.663%
11/7/2025Vanguard Group Inc.1,059,109$21.71M0.0%+15.0%5.705%
11/7/2025JPMorgan Chase & Co.6,564$135K0.0%-20.3%0.035%
11/6/2025 Rhumbline Advisers32,414$664K0.0%-10.2%0.175%
11/6/2025 Wesbanco Bank Inc.10,000$205K0.0%N/A0.054%
11/4/2025State of Wyoming21,833$448K0.1%N/A0.118%
11/4/2025 Principal Financial Group Inc.18,826$386K0.0%N/A0.101%
10/31/2025 Perkins Capital Management Inc.37,596$771K0.7%-3.8%0.203%
10/30/2025 Strs Ohio24,500$502K0.0%N/A0.132%
10/21/2025Global Retirement Partners LLC2,199$45K0.0%-20.0%0.012%
10/20/2025 Calamos Advisors LLC77,002$1.58M0.0%+66.8%0.415%
10/20/2025 Brendel Financial Advisors LLC17,054$350K0.2%N/A0.092%
NNVC FDA = New Momentum Wave! (Ad)

NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance.tc pixel

See why this FDA milestone could be a catalyst for NNVC
10/16/2025Rice Hall James & Associates LLC545,816$11.19M0.6%-10.2%2.940%
10/15/2025 Harbor Capital Advisors Inc.22,168$454K0.0%N/A0.119%
10/10/2025 USA Financial Formulas6,409$131K0.0%N/A0.035%
8/15/2025Manatuck Hill Partners LLC455,000$6.14M2.3%+139.5%2.450%
8/15/2025Massar Capital Management LP22,000$297K0.2%N/A0.118%
8/15/2025 BNP Paribas Financial Markets4,074$55K0.0%+119.2%0.022%
8/15/2025Balyasny Asset Management L.P.156,338$2.11M0.0%N/A0.842%
8/15/2025Bank of America Corp DE34,242$462K0.0%-7.7%0.184%
8/15/2025Ameriprise Financial Inc.69,880$943K0.0%N/A0.376%
8/14/2025Raymond James Financial Inc.84,555$1.14M0.0%N/A0.455%


OPRX Institutional Ownership - Frequently Asked Questions

During the previous two years, 110 institutional investors and hedge funds held shares of OptimizeRx. The most heavily invested institutionals were Vanguard Group Inc. ($21.71M), First Light Asset Management LLC ($18.27M), Kennedy Capital Management LLC ($13.84M), Divisadero Street Capital Management LP ($13.16M), Whetstone Capital Advisors LLC ($13.06M), Parkman Healthcare Partners LLC ($10.45M), and Royce & Associates LP ($8.36M).Learn more on OptimizeRx's institutional investors.

76.47% of OptimizeRx's stock is owned by institutional investors. Learn more on OPRX's institutional investor holdings.

Of the 100 institutional investors that purchased OptimizeRx's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Whetstone Capital Advisors LLC ($1.51M), Royce & Associates LP ($1.07M), Invesco Ltd. ($492.65K), Parkman Healthcare Partners LLC ($477.19K), Kennedy Capital Management LLC ($420.12K), Manatuck Hill Partners LLC ($382.31K), and CenterBook Partners LP ($308.81K).

Institutional investors have bought a total of 4,526,353 shares in the last 24 months. This purchase volume represents approximately $67.36M in transactions.

Of the 29 institutional investors that sold OptimizeRx's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: CenterBook Partners LP ($283.59K), Schonfeld Strategic Advisors LLC ($182.00K), Marshall Wace LLP ($154.75K), Royce & Associates LP ($113.31K), Renaissance Technologies LLC ($78.32K), UBS Group AG ($68.57K), and Rice Hall James & Associates LLC ($61.74K).

Institutional investors have sold a total of 1,289,078 shares in the last 24 months. This volume of shares sold represents approximately $20.52M in transactions.


Related Companies

This page (NASDAQ:OPRX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...
Equiscreen | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Elon’s ‘iPhone’ Could 10x Apple’s iPhone
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel